• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Exploratory Bronchoalveolar Lavage Fluid Analyses Reveal a High Diversity of Microbiome in NTM Lung Disease and a Low Diversity of Microbiome in Bronchiectasis.

作者信息

Fujita Kohei, Yamamoto Yuki, Kamita Masahiro, Tanaka Kosei, Nakabayashi Takeru, Imakita Takuma, Oi Issei, Kanai Osamu, Mio Tadashi, Tanizawa Kiminobu, Ito Yutaka

机构信息

Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

HiLung, Inc., Kyoto, Japan.

出版信息

Open Respir Arch. 2024 Jun 22;6(4):100351. doi: 10.1016/j.opresp.2024.100351. eCollection 2024 Oct-Dec.

DOI:10.1016/j.opresp.2024.100351
PMID:39185443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11341927/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d6/11341927/a73408636f09/gr1af.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d6/11341927/a73408636f09/gr1af.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d6/11341927/a73408636f09/gr1af.jpg

相似文献

1
Exploratory Bronchoalveolar Lavage Fluid Analyses Reveal a High Diversity of Microbiome in NTM Lung Disease and a Low Diversity of Microbiome in Bronchiectasis.探索性支气管肺泡灌洗流体分析揭示了非结核分枝杆菌肺病中微生物群的高度多样性以及支气管扩张症中微生物群的低多样性。
Open Respir Arch. 2024 Jun 22;6(4):100351. doi: 10.1016/j.opresp.2024.100351. eCollection 2024 Oct-Dec.
2
Characterization of bronchoalveolar lavage fluid microbiota in acute exacerbations of bronchiectasis with non-tuberculous mycobacterial detection.支气管扩张症急性加重期非结核分枝杆菌检测时支气管肺泡灌洗液微生物群落特征。
Int J Infect Dis. 2024 Sep;146:107120. doi: 10.1016/j.ijid.2024.107120. Epub 2024 May 29.
3
[Analysis of time for diagnosis of nontuberculous mycobacterial lung disease and its associated factors in a tuberculosis-designated hospital in Shanghai].[上海市某结核病定点医院非结核分枝杆菌肺病诊断时间及其相关因素分析]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):380-387. doi: 10.3760/cma.j.cn112147-20230111-00018.
4
Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.临床稳定期和加重期支气管扩张症患者肺部微生物群的差异
PLoS One. 2017 Aug 22;12(8):e0183553. doi: 10.1371/journal.pone.0183553. eCollection 2017.
5
The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study.支气管扩张伴固定气流阻塞患者肺部微生物组的临床影响：一项前瞻性队列研究。
Respir Res. 2024 Aug 14;25(1):308. doi: 10.1186/s12931-024-02931-x.
6
The value of gene chip detection of bronchoalveolar lavage fluid in the diagnosis of nontuberculous mycobacterial lung disease.支气管肺泡灌洗液基因芯片检测在非结核分枝杆菌肺病诊断中的价值
Ann Palliat Med. 2021 Jun;10(6):6438-6445. doi: 10.21037/apm-21-1205. Epub 2021 Jun 21.
7
Prevalence and subtyping of biofilms present in bronchoalveolar lavage from children with protracted bacterial bronchitis or non-cystic fibrosis bronchiectasis: a cross-sectional study.在患有迁延性细菌性支气管炎或非囊性纤维化性支气管扩张症的儿童的支气管肺泡灌洗液中存在生物膜的流行情况和亚型：一项横断面研究。
Lancet Microbe. 2022 Mar;3(3):e215-e223. doi: 10.1016/S2666-5247(21)00300-1. Epub 2022 Feb 1.
8
Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study.非结核分枝杆菌肺病和支气管扩张症患者衰弱的比较：一项前瞻性队列研究。
BMC Pulm Med. 2022 Nov 3;22(1):395. doi: 10.1186/s12890-022-02206-5.
9
Possible role of anaerobes in the pathogenesis of nontuberculous mycobacterial infection.可能的厌氧菌在非结核分枝杆菌感染发病机制中的作用。
Respirology. 2015 Jul;20(5):758-65. doi: 10.1111/resp.12536. Epub 2015 Mar 30.
10
Smoking related environmental microbes affecting the pulmonary microbiome in Chinese population.吸烟相关的环境微生物影响中国人群的肺部微生物组。
Sci Total Environ. 2022 Jul 10;829:154652. doi: 10.1016/j.scitotenv.2022.154652. Epub 2022 Mar 18.

引用本文的文献

1
The gut-lung axis and microbiome dysbiosis in non-tuberculous mycobacterial infections: immune mechanisms, clinical implications, and therapeutic frontiers.非结核分枝杆菌感染中的肠-肺轴与微生物群失调：免疫机制、临床意义及治疗前沿
Gut Pathog. 2025 Jun 6;17(1):40. doi: 10.1186/s13099-025-00718-z.

本文引用的文献

1
Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病患者的肺部和肠道微生物群多样性减少。
Korean J Intern Med. 2023 Nov;38(6):879-892. doi: 10.3904/kjim.2023.097. Epub 2023 Oct 23.
2
Lower Airway Dysbiosis Augments Lung Inflammatory Injury in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.下呼吸道微生态失调加重轻中度慢性阻塞性肺疾病肺部炎症损伤。
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1101-1114. doi: 10.1164/rccm.202210-1865OC.
3
Characteristics and intrasubject variation in the respiratory microbiome in interstitial lung disease.
间质性肺疾病患者的呼吸微生物组特征及其个体内变异性。
Medicine (Baltimore). 2023 Apr 7;102(14):e33402. doi: 10.1097/MD.0000000000033402.
4
Lower airway microbiota in patients with clinically suspected complex lung disease.临床疑似复杂肺部疾病患者的下呼吸道微生物群
Heliyon. 2021 Jun 11;7(6):e07283. doi: 10.1016/j.heliyon.2021.e07283. eCollection 2021 Jun.
5
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.非结核分枝杆菌肺病治疗：美国胸科学会/欧洲呼吸学会/欧洲临床微生物学和传染病学会/美国感染病学会临床实践指南
Clin Infect Dis. 2020 Aug 14;71(4):e1-e36. doi: 10.1093/cid/ciaa241.
6
Evaluation of the airway microbiome in nontuberculous mycobacteria disease.非结核分枝杆菌病气道微生物组评估。
Eur Respir J. 2018 Oct 25;52(4). doi: 10.1183/13993003.00810-2018. Print 2018 Oct.
7
Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype.口腔分类群使肺部微生物组富集与 Th17 表型的肺部炎症有关。
Nat Microbiol. 2016 Apr 4;1:16031. doi: 10.1038/nmicrobiol.2016.31.
8
Possible role of anaerobes in the pathogenesis of nontuberculous mycobacterial infection.可能的厌氧菌在非结核分枝杆菌感染发病机制中的作用。
Respirology. 2015 Jul;20(5):758-65. doi: 10.1111/resp.12536. Epub 2015 Mar 30.
9
Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease.慢性共感染在肺部鸟分枝杆菌复合群疾病中的流行情况和危险因素。
BMJ Open Respir Res. 2014 Aug 28;1(1):e000050. doi: 10.1136/bmjresp-2014-000050. eCollection 2014.
10
Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.支气管扩张症患者在临床稳定期和加重期的肺部微生物群和细菌丰度。
Am J Respir Crit Care Med. 2013 May 15;187(10):1118-26. doi: 10.1164/rccm.201210-1937OC.